You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國元證券:研發實力領先,維持中國飛鶴“買入”評級
中國飛鶴(6186.HK)日前公吿年報顯示,2023收入195.32億元,歸母淨利33.90億元。公司每股擬發放末期股息0.1484港元,結合中期股息每股0.1349港元,股息率約達7.70%。國元證券發佈研報點評中國飛鶴2023年報稱,中國飛鶴研發實力領先,產品結構持續升級。公司作為中國嬰配粉行業領軍企業,2023年,飛鶴率先推出了國內首款HMO奶粉——星飛帆卓睿4段,使產品更大程度地還原了中國母乳活性營養,推動國內奶粉產業持續高質量發展。隨着公司持續推動以星飛帆、卓睿為代表的高端產品的結構升級,公司業績有望持續增長,維持“買入”評級。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account